Cargando…

Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia

Trachoma is caused by Chlamydia trachomatis (Ct). It is targeted for global elimination as a public health problem. In 2014, a population-based cross-sectional study was performed in two previously trachoma-endemic areas of The Gambia. Participants of all ages from Lower River Region (LRR) (N = 1028...

Descripción completa

Detalles Bibliográficos
Autores principales:	Migchelsen, Stephanie J., Sepúlveda, Nuno, Martin, Diana L., Cooley, Gretchen, Gwyn, Sarah, Pickering, Harry, Joof, Hassan, Makalo, Pateh, Bailey, Robin, Burr, Sarah E., Mabey, David C. W., Solomon, Anthony W., Roberts, Chrissy h.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678181/ https://www.ncbi.nlm.nih.gov/pubmed/29118442 http://dx.doi.org/10.1038/s41598-017-15056-7

Ejemplares similares

Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies
por: Migchelsen, Stephanie J., et al.
Publicado: (2017)

A systems serology approach to the investigation of infection-induced antibody responses and protection in trachoma
por: Barton, Amber, et al.
Publicado: (2023)

Conjunctival Microbiome-Host Responses Are Associated With Impaired Epithelial Cell Health in Both Early and Late Stages of Trachoma
por: Pickering, Harry, et al.
Publicado: (2019)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
por: Harding-Esch, Emma M., et al.
Publicado: (2013)

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
por: Harding-Esch, Emma M., et al.
Publicado: (2013)

The utility of serology for elimination surveillance of trachoma
por: Pinsent, Amy, et al.
Publicado: (2018)

Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities
por: Burton, Matthew J., et al.
Publicado: (2010)

Conjunctival MicroRNA Expression in Inflammatory Trachomatous Scarring
por: Derrick, Tamsyn, et al.
Publicado: (2013)

The conjunctival microbiome in health and trachomatous disease: a case control study
por: Zhou, Yanjiao, et al.
Publicado: (2014)

Differential frequency of NKG2C/KLRC2 deletion in distinct African populations and susceptibility to Trachoma: a new method for imputation of KLRC2 genotypes from SNP genotyping data
por: Goncalves, Adriana, et al.
Publicado: (2016)

Profiling and validation of individual and patterns of Chlamydia trachomatis-specific antibody responses in trachomatous trichiasis
por: Pickering, Harry, et al.
Publicado: (2017)

Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors
por: Edwards, Tansy, et al.
Publicado: (2014)

Association between Ocular Bacterial Carriage and Follicular Trachoma Following Mass Azithromycin Distribution in The Gambia
por: Burr, Sarah E., et al.
Publicado: (2013)

Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji
por: Cocks, Naomi, et al.
Publicado: (2016)

Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger
por: Kim, Jessica S., et al.
Publicado: (2019)

Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea
por: Macleod, Colin K, et al.
Publicado: (2020)

Monitoring transmission intensity of trachoma with serology
por: Tedijanto, Christine, et al.
Publicado: (2023)

Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem
por: Senyonjo, Laura G., et al.
Publicado: (2018)

Monitoring transmission intensity of trachoma with serology
por: Tedijanto, Christine, et al.
Publicado: (2023)

Trachoma Prevalence and Associated Risk Factors in The Gambia and Tanzania: Baseline Results of a Cluster Randomised Controlled Trial
por: Harding-Esch, Emma M., et al.
Publicado: (2010)

Genome-wide profiling of humoral immunity and pathogen genes under selection identifies immune evasion tactics of Chlamydia trachomatis during ocular infection
por: Pickering, Harry, et al.
Publicado: (2017)

The Gambia has eliminated trachoma as a public health problem: Challenges and successes
por: Aboe, Agatha, et al.
Publicado: (2022)

Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study
por: Harding-Esch, Emma, et al.
Publicado: (2015)

The use of serology for trachoma surveillance: Current status and priorities for future investigation
por: Martin, Diana L., et al.
Publicado: (2020)

Serology describes a profile of declining malaria transmission in Farafenni, The Gambia
por: van den Hoogen, Lotus L., et al.
Publicado: (2015)

Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units
por: Burr, Sarah E., et al.
Publicado: (2019)

Serology for Trachoma Surveillance after Cessation of Mass Drug Administration
por: Martin, Diana L., et al.
Publicado: (2015)

Cross-Sectional Surveys of the Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination Been Reached?
por: Burr, Sarah E., et al.
Publicado: (2016)

Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma
por: Butcher, Robert, et al.
Publicado: (2020)

Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: a cross-sectional population-based study
por: Last, Anna, et al.
Publicado: (2017)

Trachoma and Ocular Chlamydial Infection in the Era of Genomics
por: Derrick, Tamsyn, et al.
Publicado: (2015)

An outbreak of acute haemorrhagic conjunctivitis associated with coxsackievirus A24 variant in The Gambia, West Africa
por: Burr, Sarah E., et al.
Publicado: (2017)

No Serological Evidence of Trachoma or Yaws Among Residents of Registered Camps and Makeshift Settlements in Cox’s Bazar, Bangladesh
por: Cooley, Gretchen M., et al.
Publicado: (2021)

The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa
por: Last, Anna R., et al.
Publicado: (2017)

Responses of the putative trachoma vector, Musca sorbens, to volatile semiochemicals from human faeces
por: Robinson, Ailie, et al.
Publicado: (2020)

Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau
por: Last, Anna R., et al.
Publicado: (2014)

Conjunctival FOXP3 Expression in Trachoma: Do Regulatory T Cells Have a Role in Human Ocular Chlamydia trachomatis Infection?
por: Faal, Nkoyo, et al.
Publicado: (2006)

Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati
por: Cama, Anaseini, et al.
Publicado: (2017)

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ov33iurkrldd4ne295kfpftud9